These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A case of fetal intestinal tract distensions: prenatal biochemical and ultrasound evaluation. Stefos T; Georgiou I; Syrrou M; Lollis D Fetal Diagn Ther; 1993; 8(3):211-3. PubMed ID: 8240697 [TBL] [Abstract][Full Text] [Related]
27. The meaning of intraabdominal bowel dilation in fetuses with gastroschisis. Salomon LJ; Ville Y; Khen-Dunlop N Am J Obstet Gynecol; 2010 Dec; 203(6):e9-10; author reply e10. PubMed ID: 20739010 [No Abstract] [Full Text] [Related]
28. Placental pathology casebook. Liveborn twin of an extramembranous pregnancy. Baergen RN; Boué DR; Mannino F J Perinatol; 1995; 15(6):510-3. PubMed ID: 8648462 [No Abstract] [Full Text] [Related]
29. Prevalence of cystic fibrosis mutations in pregnancies with fetal echogenic bowel. Sepulveda W; Leung KY; Robertson ME; Kay E; Mayall ES; Fisk NM Obstet Gynecol; 1996 Jan; 87(1):103-6. PubMed ID: 8532242 [TBL] [Abstract][Full Text] [Related]
30. Prenatal ultrasonographic findings associated with short bowel syndrome in two fetuses with gastroschisis. McMahon MJ; Kuller JA; Chescheir NC Obstet Gynecol; 1996 Oct; 88(4 Pt 2):676-8. PubMed ID: 8841249 [TBL] [Abstract][Full Text] [Related]
32. Hyperechogenic bowel in the second trimester fetus: a review. Penna L; Bower S Prenat Diagn; 2000 Nov; 20(11):909-13. PubMed ID: 11113894 [No Abstract] [Full Text] [Related]
33. Non-echogenic nuchal oedema as a marker in trisomy 21 screening. van Zalen-Sprock MM; van Vugt JM; van Geijn HP Lancet; 1992 Jun; 339(8807):1480-1. PubMed ID: 1351151 [No Abstract] [Full Text] [Related]
34. Is fetal hyperechoic bowel on second-trimester sonogram an indication for amniocentesis? Bromley B; Doubilet P; Frigoletto FD; Krauss C; Estroff JA; Benacerraf BR Obstet Gynecol; 1994 May; 83(5 Pt 1):647-51. PubMed ID: 8164918 [TBL] [Abstract][Full Text] [Related]
35. Ultrasound diagnosis and screening of fetal cystic fibrosis. Török O; Tóth Z; Szabó M; Papp Z Acta Univ Carol Med (Praha); 1990; 36(1-4):139-41. PubMed ID: 2130676 [TBL] [Abstract][Full Text] [Related]
36. Bayesian risk assessment for autosomal recessive diseases: fetal echogenic bowel with one or no detectable CFTR mutation. Ogino S; Wilson RB; Grody WW J Med Genet; 2004 May; 41(5):e70. PubMed ID: 15121798 [No Abstract] [Full Text] [Related]
37. Dilated and echogenic fetal bowel and postnatal outcomes: a surgical perspective. Case series and literature review. Jackson CR; Orford J; Minutillo C; Dickinson JE Eur J Pediatr Surg; 2010 May; 20(3):191-3. PubMed ID: 20175047 [TBL] [Abstract][Full Text] [Related]
38. The risk of cystic fibrosis with prenatally detected echogenic bowel in an ethnically and racially diverse North American population. Monaghan KG; Feldman GL Prenat Diagn; 1999 Jul; 19(7):604-9. PubMed ID: 10419606 [TBL] [Abstract][Full Text] [Related]
39. Down's syndrome screening with nuchal translucency. Hackshaw AK; Wald NJ; Haddow JE Lancet; 1996 Dec 21-28; 348(9043):1740. PubMed ID: 8973459 [No Abstract] [Full Text] [Related]